(IBTA) Ibotta - Ratings and Ratios
Digital Promotions, Ad Products, IPN, Retailer Services, Publisher Tools
EPS (Earnings per Share)
Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 91.3% |
| Value at Risk 5%th | 122% |
| Relative Tail Risk | -18.76% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.87 |
| Alpha | -79.07 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.224 |
| Beta | 1.206 |
| Beta Downside | 1.155 |
| Drawdowns 3y | |
|---|---|
| Max DD | 79.26% |
| Mean DD | 48.76% |
| Median DD | 49.35% |
Description: IBTA Ibotta November 15, 2025
Ibotta, Inc. (NYSE:IBTA) operates a technology-driven promotion platform that partners with consumer packaged goods (CPG) brands to digitize coupons and rebates, then distributes those offers to shoppers via its Ibotta Performance Network (IPN). The IPN powers direct-to-consumer mobile, web and browser-extension experiences as well as integrations with third-party publishers, delivering ad formats such as display tiles, sponsored offers, newsletters and premium feature placements.
As of FY 2023, Ibotta reported roughly $500 million in revenue and a monthly active user base exceeding 45 million, reflecting a 30 % YoY increase in engagement driven by higher smartphone penetration and rising consumer interest in cash-back incentives amid inflationary pressure. The company’s growth is further supported by a broader shift in the advertising sector toward performance-based, data-rich campaigns, where advertisers increasingly allocate spend to measurable, redemption-linked media. Ibotta’s margins remain sensitive to the cost of acquiring and retaining users, which is influenced by competitive loyalty-app ecosystems and the overall health of discretionary consumer spending.
For a deeper, data-driven look at Ibotta’s valuation dynamics and scenario analysis, you might explore the analyst tools available on ValueRay.
IBTA Stock Overview
| Market Cap in USD | 631m |
| Sub-Industry | Advertising |
| IPO / Inception | 2024-04-18 |
| Return 12m vs S&P 500 | -67.9% |
| Analyst Rating | 3.78 of 5 |
IBTA Dividends
Currently no dividends paidIBTA Growth Ratios
| Metric | Value |
|---|---|
| CAGR 3y | -57.22% |
| CAGR/Max DD Calmar Ratio | -0.72 |
| CAGR/Mean DD Pain Ratio | -1.17 |
| Current Volume | 452.9k |
| Average Volume | 323.3k |
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (88.0m TTM) > 0 and > 6% of Revenue (6% = 21.1m TTM) |
| FCFTA 0.12 (>2.0%) and ΔFCFTA -5.10pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 70.67% (prev 98.92%; Δ -28.25pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.16 (>3.0%) and CFO 89.5m > Net Income 88.0m (YES >=105%, WARN >=100%) |
| Net Debt (-198.0m) to EBITDA (30.7m) ratio: -6.46 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.21 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (31.0m) change vs 12m ago -7.65% (target <= -2.0% for YES) |
| Gross Margin 80.89% (prev 87.17%; Δ -6.28pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 60.33% (prev 61.60%; Δ -1.27pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 6.59 (EBITDA TTM 30.7m / Interest Expense TTM 3.69m) >= 6 (WARN >= 3) |
Altman Z'' 1.77
| (A) 0.44 = (Total Current Assets 455.5m - Total Current Liabilities 206.5m) / Total Assets 569.4m |
| (B) -0.24 = Retained Earnings (Balance) -135.9m / Total Assets 569.4m |
| (C) 0.04 = EBIT TTM 24.3m / Avg Total Assets 583.9m |
| (D) -0.57 = Book Value of Equity -135.9m / Total Liabilities 239.8m |
| Total Rating: 1.77 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 82.56
| 1. Piotroski 5.50pt |
| 2. FCF Yield 16.34% |
| 3. FCF Margin 20.09% |
| 4. Debt/Equity 0.08 |
| 5. Debt/Ebitda -6.46 |
| 6. ROIC - WACC (= 7.33)% |
| 7. RoE 22.83% |
| 8. Rev. Trend 58.47% |
| 9. EPS Trend 31.78% |
What is the price of IBTA shares?
Over the past week, the price has changed by -8.77%, over one month by -29.25%, over three months by -16.98% and over the past year by -64.08%.
Is IBTA a buy, sell or hold?
- Strong Buy: 2
- Buy: 3
- Hold: 4
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the IBTA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 29.1 | 27.9% |
| Analysts Target Price | 29.1 | 27.9% |
| ValueRay Target Price | 17.4 | -23.8% |
IBTA Fundamental Data Overview November 15, 2025
P/E Trailing = 6.1376
P/E Forward = 24.6914
P/S = 1.7166
P/B = 2.1523
Beta = None
Revenue TTM = 352.2m USD
EBIT TTM = 24.3m USD
EBITDA TTM = 30.7m USD
Long Term Debt = unknown (none)
Short Term Debt = 1.55m USD (from shortTermDebt, last fiscal year)
Debt = 25.3m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -198.0m USD (from netDebt column, last quarter)
Enterprise Value = 433.1m USD (631.0m + Debt 25.3m - CCE 223.3m)
Interest Coverage Ratio = 6.59 (Ebit TTM 24.3m / Interest Expense TTM 3.69m)
FCF Yield = 16.34% (FCF TTM 70.8m / Enterprise Value 433.1m)
FCF Margin = 20.09% (FCF TTM 70.8m / Revenue TTM 352.2m)
Net Margin = 25.00% (Net Income TTM 88.0m / Revenue TTM 352.2m)
Gross Margin = 80.89% ((Revenue TTM 352.2m - Cost of Revenue TTM 67.3m) / Revenue TTM)
Gross Margin QoQ = 79.41% (prev 79.16%)
Tobins Q-Ratio = 0.76 (Enterprise Value 433.1m / Total Assets 569.4m)
Interest Expense / Debt = 14.54% (Interest Expense 3.69m / Debt 25.3m)
Taxrate = -120.5% (out of range, set to none) (-6.33m / 5.25m)
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 2.21 (Total Current Assets 455.5m / Total Current Liabilities 206.5m)
Debt / Equity = 0.08 (Debt 25.3m / totalStockholderEquity, last quarter 329.6m)
Debt / EBITDA = -6.46 (Net Debt -198.0m / EBITDA 30.7m)
Debt / FCF = -2.80 (Net Debt -198.0m / FCF TTM 70.8m)
Total Stockholder Equity = 385.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 15.46% (Net Income 88.0m / Total Assets 569.4m)
RoE = 22.83% (Net Income TTM 88.0m / Total Stockholder Equity 385.6m)
RoCE = 6.69% (EBIT 24.3m / Capital Employed (Total Assets 569.4m - Current Liab 206.5m))
RoIC = 17.39% (EBIT 24.3m / (Assets 569.4m - Curr.Liab 206.5m - Cash 223.3m))
WACC = 10.06% (E(631.0m)/V(656.4m) * Re(10.46%) + (debt cost/tax rate unavailable))
Discount Rate = 10.46% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 1.25%
[DCF Debug] Terminal Value 73.99% ; FCFE base≈84.4m ; Y1≈104.1m ; Y5≈177.7m
Fair Price DCF = 79.81 (DCF Value 2.02b / Shares Outstanding 25.3m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 31.78 | EPS CAGR: 42.27% | SUE: 0.27 | # QB: 0
Revenue Correlation: 58.47 | Revenue CAGR: 8.65% | SUE: 0.19 | # QB: 0
Additional Sources for IBTA Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle